Highlight
Summary
About the Role
About You
- An advanced degree in Life Sciences, Pharmacy, or related field.
- 10+ years of experience in GCP quality/compliance, including 5+ years in a leadership role.
- Deep knowledge of ICH-GCP, FDA, EMA, and other global regulatory requirements.
- Proven success leading inspection readiness and serving as the primary interface with global health authorities during inspections and audits.
- Experience in the biotech or pharmaceutical industry, ideally in late-stage clinical development.
- Strong leadership, communication, and influencing capabilities.
- Strategic thinking with operational execution skills.
- High integrity and commitment to ethical research practices.
Benefits
- Health insurance premiums paid at 90% for employee, 80% for dependents.
- Free access to Genentech Bus & Ferry Share program.
- $100 monthly cell phone stipend.
- Unlimited PTO for Exempt employees.
- Free onsite gym and a kitchen stocked with snacks and drinks.
- Generous stock option grants for all employees and an annual bonus program.
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.